Earnings Feed
Start Free
10x Genomics, Inc.·4

Feb 25, 4:52 PM ET

Saxonov Serge 4

4 · 10x Genomics, Inc. · Filed Feb 25, 2026

Insider Transaction Report

Form 4
Period: 2026-02-23
10x Genomics, Inc.TXG
Saxonov Serge
DirectorChief Executive Officer
Transactions
  • Sale

    Class A Common Stock

    [F1]
    2026-02-23$18.58/sh−9,632$178,928→ 1,061,924 total
Holdings

  • Class A Common Stock

    [F2]
    (indirect: See footnote)
    27

  • Class A Common Stock

    [F3]
    (indirect: See footnote)
    213,250

  • Class A Common Stock

    [F4]
    (indirect: See footnote)
    58,000
Footnotes (4)
  • [F1]The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
  • [F3]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
  • [F4]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
Signature
/s/ Randy Wu, as Attorney-in-Fact for Serge Saxonov|2026-02-25

Documents

2 files
  • 4
    form4.xmlPrimary
  • EX-24.1
    poa.htm

    POWER OF ATTORNEY